Together with the evidence that Il17a-/- aged mice had smaller TLOs after renal ischemia reperfusion injury, the administration of blocking antibodies to IL-17A also reduced the development of TLOs correlating with a modest reduction in renal fibrosis. The gene discussed is IL17A; the disease is renal fibrosis.